The Impact of Atrial Prevention and Termination Therapies on Atrial Tachyarrhythmia Burden in Patients Receiving a Dual-Chamber Defibrillator for Ventricular Arrhythmias

By Friedman Paul A.   Ip John H.   Jazayeri Mohammad   Lobban John H.   Olshansky Brian   Zhou Duo   Knowles Tracy   Euler David E.    

Journal of Interventional Cardiac Electrophysiology, Vol. 10, Iss. 2, 2004-04 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness of Rapid Atrial Pacing for Termination of Drug Refractory Atrial Fibrillation: Results of a Dual Chamber Implantable Cardioverter Defibrillator Trial

By Gold M.R.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 341-344

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of Atrial Antitachycardia Functions for Treating Atrial Fibrillation: Observations in Patients with a Dual-Chamber Defibrillator

By Ricci R.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 348-351

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of perception of health status by physicians, nurses, and patients in the Dual-chamber And VVI Implantable Defibrillator (DAVID) trial

By Epstein A.E.   Swarens A.   Skadsen A.   Murphy S.W.   Ellenbogen K.A.   Gebhardt L.   the DAVID Investigators  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 120-121

Elsevier

Access to resources Recommend Favorite

Rationale and Patient Selection for “Hybrid” Drug and Device Therapy in Atrial and Ventricular Arrhythmias

By Camm A.J.   Savelieva I.  

Journal of Interventional Cardiac Electrophysiology, Vol. 9, Iss. 2, 2003-10 ,pp. : 207-214

Springer Publishing Company

Access to resources Recommend Favorite